BioAtla, Inc. Common Stock

BCAB Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
BCAB Income Statement
BCAB Balance Sheet
BCAB Cash Flow
Congress Trading

Recent trades of BCAB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
BCAB Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BCAB Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BCAB Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by BCAB's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Conditionally active biological proteins Oct. 08, 2024
  • Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts May. 07, 2024
  • Patent Title: Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof Feb. 13, 2024
  • Patent Title: Anti-ror2 antibodies, antibody fragments, their immunoconjucates and uses thereof Jan. 23, 2024
  • Patent Title: Conditionally active anti-epcam antibodies, antibody fragments, their immunoconjugates and uses thereof Dec. 26, 2023
  • Patent Title: Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof Dec. 05, 2023
  • Patent Title: Conditionally active polypeptides and methods of generating them Oct. 03, 2023
  • Patent Title: Mirac proteins Aug. 08, 2023
  • Patent Title: Methods of protein evolution May. 02, 2023
  • Patent Title: Conditionally active chimeric antigen receptors for modified t-cells Feb. 21, 2023
  • Patent Title: Anti-ctla4 antibodies, antibody fragments, their immunoconjugates and uses thereof Jan. 03, 2023
  • Patent Title: Conditionally active polypeptides Oct. 18, 2022
  • Patent Title: Comprehensive monoclonal antibody generation Jul. 26, 2022
  • Patent Title: Express humanization of antibodies Jul. 26, 2022
  • Patent Title: Proteins targeting orthologs Apr. 05, 2022
  • Patent Title: Conditionally active polypeptides and methods of generating them Mar. 22, 2022
  • Patent Title: Conditionally active biological proteins Feb. 22, 2022
  • Patent Title: Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof Feb. 22, 2022
  • Patent Title: Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof Oct. 19, 2021
  • Patent Title: Conditionally active chimeric antigen receptors for modified t-cells Sep. 07, 2021
  • Patent Title: Modified antibody regions and uses thereof Mar. 23, 2021
  • Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Feb. 16, 2021
  • Patent Title: Methods of protein evolution Nov. 10, 2020
  • Patent Title: Diagnostics using conditionally active antibodies Jun. 30, 2020
  • Patent Title: Multi-specific monoclonal antibodies Jun. 30, 2020
  • Patent Title: Comprehensive monoclonal antibody generation Jun. 02, 2020
  • Patent Title: Express humanization of antibodies Feb. 18, 2020
  • Patent Title: Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts Dec. 24, 2019
  • Patent Title: Conditionally active biological proteins Jun. 25, 2019
  • Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Oct. 23, 2018
  • Patent Title: Methods of protein evolution Oct. 23, 2018
  • Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Aug. 14, 2018
  • Patent Title: Mirac proteins Jun. 12, 2018
  • Patent Title: Mirac proteins May. 29, 2018
  • Patent Title: Multi-specific monoclonal antibodies May. 15, 2018
  • Patent Title: Anti-cd22 antibodies Jan. 02, 2018
  • Patent Title: Mirac proteins May. 02, 2017
  • Patent Title: Mirac proteins May. 02, 2017
  • Patent Title: Mirac proteins Oct. 11, 2016
  • Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Oct. 14, 2014
  • Patent Title: Mirac proteins Apr. 29, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of BCAB in WallStreetBets Daily Discussion

BCAB News

Recent insights relating to BCAB

CNBC Recommendations

Recent picks made for BCAB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BCAB

BCAB Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BCAB Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top